Israeli cyber unicorn Claroty completes USD 400 million Series E financing and acquires Medigate
Israeli cyber unicorn Claroty hxas completed a USD 400 million Series E financing led by Softbank, as well as its purchase of Medigate, a leading Israeli healthcare IoT security company.
With these two transactions, Claroty broke two local records – the IoT cyber company with the highest total funding (USD 635 million), and the largest local acquisition in the Israeli cyber sector.
Goldfarb Seligman (“Goldfarb”) acted for Claroty throughout the financing round and acquisition. Epstein Rosenblum Maoz (“ERM”) advised SoftBank Investment Advisers, alongside White & Case LLP, as lead investor in the acquisition of Medigate.
The Goldfarb included partners Guy Gordon, Adam M. Klein and Ronen Hausirer, senior counsels Nitzan Tuvya and Gal Dayan-Sion, associates Ella Dekel, Daniel Kolko and Maya Dagan, and interns Karen Mintz, Nour Gandour, Oren Mazigh and Tal Almog of our International Corporate and Securities Department; partners Yaron Sever and Sagit Shoval-Moked and associate Yarden Ravivo of our Tax Department; partner Revital Shprung-Levy and associates Idan Ashush and Lior Dekel of our Labor and Corporate Immigration Department.
The ERM team included partner Jeremy Seeff, together with associate Jonathan Zerker, employment partner Eti Avnery and associate Yarden Arad.
